April 4, 2024 — Siemens Healthineers announces the Food and Drug Administration 510(k) clearance of the MAMMOMAT B.brilliant — the first completely redesigned mammography platform in more than 10 years. The clearance includes elements involving full-field digital mammography, breast biopsy, and titanium contrast-enhanced mammography. The system’s new features enhance user ergonomics and workflow, as well as reduce patient discomfort. The company recently filed a Premarket Approval application for the three-dimensional portion of the MAMMOMAT B.brilliant, featuring new tomosynthesis acquisition and reconstruction technology.
Siemens Healthineers Unveils Next-Generation Mammography Platform, Germany
Date:
Updated: [falahcoin_post_modified_date]